Skip to main content
Greg Harrison

Greg Harrison

Australian organic chemist and Managing Director at Chemson; leads research team analyzing amyloid protein structures in white fibrous clots.

Jul 1, 2026

CorneliaHOST
6:05
Can you, first of all, name some of these diseases? And then second, talk a little bit about what we know how this misfolding is caused.
6:17
Okay.
6:18
I can talk about the second request.
6:21
I cannot talk about the first because I'm not medically qualified in any way.
6:25
I'm not a doctor and I'm certainly not qualified to talk about the various types of amyloid diseases that are well known.
6:33
Okay.
6:34
I am aware of them.
CorneliaHOST
11:22
Is that an indication of the amount of amyloid that is found?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.